Posts In: Biotech Stocks

View Post

This Biotech Is Experiencing A Coronavirus Surge

While it could be a year or more before a vaccine for the new coronavirus is ready for market, significant…Read More

View Post

Panic Potential

Amid the panic over the new coronavirus that has led to unprecedented quarantines in China, and which has now made…Read More

View Post

A Treatment That Improves The Condition Of MS Patients Could Improve The Condition Of This Beaten-Up Biotech

Last year, this biotech firm had a $50 stock and $3 billion market cap. Today, it has a stock trading…Read More

View Post

ETFs For Biotech’s Positive Results

Amid the roller coaster of optimism and pessimism regarding trade talks with China in recent weeks, one thing that has…Read More

View Post

ETFs To Play Biotech’s Favorable Prognosis

Mergers and acquisitions. Positive pipeline-related advancements. The integration of artificial intelligence. These are some of the key trends currently favoring…Read More

View Post

A Healthy Trade (In More Ways Than One)

With the IBB biotechnology ETF poised to have its best quarter in six years and analysts seeing further upside for…Read More

View Post

Biotech’s 2019 “Plot Twist”

After a rough end to 2018, with massive fund outflows in the fourth quarter, biotech’s condition has been improving in…Read More

View Post

Biotech Is On The Mend

After finding itself among the most oversold sectors last year, biotech is having its best start to a year since…Read More

View Post

The New – And More Effective – Female Viagra: An Attractive Opportunity?

This biotech company’s drug for treating hypoactive sexual desire disorder in women is expected to receive FDA approval in early…Read More

View Post

The New Paradigm For Biotech Investing

There are very few diseases for which actual cures have been developed – but that could soon start to change.…Read More